SPI Infoamtion

1. Analyst View

2. Demographics & Healthcare Profile

2.1 Life Expectancy
2.2 Age Breakup
2.3 Hospital Beds & Doctors
2.4 Healthcare Expenditure

3. Pharmaceutical Market

3.1 Market Size & Growth
3.2 Comparative Analysis
3.3 Commercial Drugs Market
　　　3.3.1 Trends
　　　3.3.2 Imported & Domestic Drugs
　　　3.3.3 RX & OTC Drugs
　　　3.3.4 Sales Structure - By ATC Groups
　　　3.3.5 Leading Companies
　　　3.3.6 Leading Drugs
　　　3.3.7 Price Analysis
3.4 State Segment
　　　3.4.1 Drug Reimbursement Program (DLO)
　　　　　　3.4.1.1 Imported & Domestic Drugs
　　　　　　3.4.1.2 RX & OTC Drugs
　　　　　　3.4.1.3 Sales Structure - By ATC Groups
　　　　　　3.4.1.4 Leading Companies
　　　　　　3.4.1.5 Leading Drugs
　　　3.4.2 Hospital Segment
　　　　　　3.4.2.1 Imported & Domestic Drugs
　　　　　　3.4.2.2 Leading Companies
　　　　　　3.4.2.3 Leading Drugs
　　　　　　3.4.2.4 Drugs Demand - By Price
3.5 Parapharmaceutical Market
　　　3.5.1 Nutritional Supplements Market
　　　　　　3.5.1.1 Imported & Domestic Supplements
3.6 New Drugs

4. Industry Analysis

4.1 Market Driving Forces
　　　4.1.1 Aging Population
　　　4.1.2 Increasing Volume & Sales of Expensive Drugs
　　　4.1.3 Government Support & Funding
　　　4.1.4 Increasing Affordability
4.2 Growth Avenues
　　　4.2.1 Cardiovascular Drugs
　　　4.2.2 Hepatitis C
　　　4.2.3 HIV Drugs
　　　4.2.4 High Insulin Demand
　　　4.2.5 Cancer Drugs
　　　4.2.6 Generics
　　　4.2.7 Clinical Trials Market
4.3 Market Roadblocks
　　　4.3.1 Declining Population
　　　4.3.2 Drug Counterfeiting & Weak IPR Regime

5. Future Outlook (2010-2013)

5.1 Commercial Drugs Market
5.2 State Segment
5.3 Parapharmaceutical Market

6. Major Moves by Key Players

6.1 Sanofi-Aventis
6.2 Novartis International AG
6.3 Roche Group
6.4 Pharmstandard

List of Figures:
Figure 2-1: Population (Million), 2006-2009
Figure 2-2: Life Expectancy of Male & Female (Years), 2004-2009
Figure 2-3: Share of Young & Old Age Population in Total Population (2002-2008)
Figure 2-4: Number of Doctors (per '000 Population), 2004-2009
Figure 2-5: Share of Healthcare Expenditure in GDP (2006-2009)
Figure 2-6: Per Head Healthcare Expenditure (US$), 2006-2009
Figure 3-1: Pharmaceutical Market (Billion US$), 2006-2009
Figure 3-2: Pharmaceutical Market Breakup by Segment (%), 2007-2009
Figure 3-3: Global - Top Pharmaceutical Retail Markets (Billion US$), 2007
Figure 3-4: Global - Growth of Top Pharmaceutical Retail Markets (%), 2007
Figure 3-5: Global - Per Head Drug Consumption in Top Pharmaceutical Markets (US$), 2007
Figure 3-6: Global - Share of Personal & State Funding in Top Pharmaceutical Markets (2007)
Figure 3-7: Commercial Drugs Market (Billion US$), 2007-2009
Figure 3-8: Trends in Commercial Drugs Market Growth (%), 2008
Figure 3-9: Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Value (2007-2009)
Figure 3-10: Share of Imported & Domestic Drugs in Commercial Drugs Market by Sales Volume (2007-2009)
Figure 3-11: Share of RX & OTC Drugs in Commercial Drugs Market by Sales Value (2007-2009)
Figure 3-12: Share of RX & OTC Drugs in Commercial Drugs Market by Sales Volume (2007-2009)
Figure 3-13: Growth of ATC Groups in Commercial Drugs Market by Sales Value (%), 2008
Figure 3-14: Price Index for Drugs in Commercial Drugs Market (%), 2005-2008
Figure 3-15: Price Index for Imported & Domestic Drugs in Commercial Drugs Market (%), 2005-2008
Figure 3-16: Consumer Price Index (%), 2008
Figure 3-17: State Segment of Pharmaceutical Market (Billion US$), 2006-2009
Figure 3-18: Allocation under DLO Program (Billion Rubles), 2007-2009
Figure 3-19: Share of Imported & Domestic Drugs in the DLO List of Full & Trade Name (2007)
Figure 3-20: Share of Imported & Domestic Drugs under DLO Program by Sales Value (2007-2009)
Figure 3-21: Share of RX & OTC Drugs under DLO Program by Sales Value (2007-2009)
Figure 3-22: Share of RX & OTC Drugs under DLO Program by Sales Volume (2007-2009)
Figure 3-23: Share of Imported & Domestic Drugs under Hospital Segment by Sales Value (2007-2009)
Figure 3-24: Share of Imported & Domestic Drugs under Hospital Segment by Sales Volume (2007-2009)
Figure 3-25: Drugs Demand by Price under Hospital Segment (%), 2007 & 2008
Figure 3-26: Parapharmaceutical Market (Billion US$), 2007-2009
Figure 3-27: Nutritional Supplements Market (Million US$), 2005-2009
Figure 3-28: Share of Imported & Domestic Nutritional Supplements Sales Value (2007-2009)
Figure 3-29: Sales Structure of New Drugs by Value & Volume (%), 2008
Figure 4-1: Population Aged 65 Years & above (Million), 2003-2009
Figure 4-2: Commercial Drugs Demand by Price (%), 2007 & 2008
Figure 4-3: Personal Disposable Income (Billion US$), 2008-2010
Figure 4-4: Compulsory Medical Insurance Premium (Billion Rubles), 2005-2009
Figure 4-5: Share of Deaths from Cardiovascular Diseases in Total Deaths (2007 & 2030)
Figure 4-6: Hepatitis C Market (Million US$), 2009-2013
Figure 4-7: Number of HIV Patients (Million), 2007 & 2020
Figure 4-8: Anti-HIV Drugs Import (Million US$), 2004 & 2005
Figure 4-9: Number of Diagnosed Diabetes Patients (Million), 2007 & 2025
Figure 4-10: Insulin Market (Million US$), 2007-2009
Figure 4-11: Share of Deaths from Cancer in Total Deaths (2005 & 2030)
Figure 4-12: Generic Drugs Market (Billion Euro), 2006 & 2010
Figure 4-13: Number of Clinical Trials (2005-2009)
Figure 4-14: Number of Patients Recruited in Clinical Trials (2007 & 2008)
Figure 4-15: Clinical Trials by Therapeutic Area (%), 2007 & 2008
Figure 4-16: Clinical Trials by Sponsor Country (%), 2007
Figure 4-17: Forecast for Population (Million), 2010-2013
Figure 5-1: Forecast for Pharmaceutical Market (Billion US$), 2010-2013
Figure 5-2: Forecast for Pharmaceutical Market Breakup by Segment (%), 2013
Figure 5-3: Forecast for Commercial Drugs Market (Billion US$), 2010-2013
Figure 5-4: Forecast for State Segment of Pharmaceutical Market (Billion US$), 2010-2013
Figure 5-5: Forecast for Personal Disposable Income (Billion US$), 2010-2013
Figure 5-6: Forecast for Parapharmaceutical Market (Billion US$), 2010-2013

List of Tables:
Table 3-1: Sales Structure of ATC Groups in Commercial Drugs Market (2008)
Table 3-2: Leading Pharmaceutical Companies in Commercial Drugs Market by Sales (Million Rubles), 2008
Table 3-3: Leading Drugs in Commercial Drugs Market by Sales (Million Rubles), 2008
Table 3-4: Drugs Sales Structure of ATC Groups under DLO Program (2008)
Table 3-5: ATC Groups under DLO Program in Sales Proportion (%), 2006-2009
Table 3-6: Leading Pharmaceutical Companies under DLO Program (Million Rubles), 2008
Table 3-7: Leading Drugs under DLO Program by Sales (Million Rubles), 2008
Table 3-8: Leading Pharmaceutical Companies under Hospital Segment (%), 2008
Table 3-9: Leading Trade Names under Hospital Segment by Sales (Million Rubles), 2008
Table 3-10: Leading New Trade Names on Commercial Market by Sales (Million Rubles), 2008
Table 4-1: Number of Clinical Trials by Top Five Sponsors (2008)